Bellicum Pharmaceuticals, Inc. 13D and 13G filings for Bellicum Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-11-18 3:01 pm Purchase |
2022-09-30 | 13D | Bellicum Pharmaceuticals, Inc. BLCM |
BELLICUM PHARMACEUTICALS INC BLCM |
691,639 7.400% |
691,639 (New Position) |
Filing |